WO2008075427A1 - 包接化合物、硬化触媒、硬化樹脂形成用組成物及び硬化樹脂 - Google Patents
包接化合物、硬化触媒、硬化樹脂形成用組成物及び硬化樹脂 Download PDFInfo
- Publication number
- WO2008075427A1 WO2008075427A1 PCT/JP2006/325472 JP2006325472W WO2008075427A1 WO 2008075427 A1 WO2008075427 A1 WO 2008075427A1 JP 2006325472 W JP2006325472 W JP 2006325472W WO 2008075427 A1 WO2008075427 A1 WO 2008075427A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- formula
- compound represented
- epoxy
- cured resin
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 100
- 229920005989 resin Polymers 0.000 title claims abstract description 30
- 239000011347 resin Substances 0.000 title claims abstract description 30
- 239000003054 catalyst Substances 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title claims description 23
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract description 117
- -1 isophthalic acid compound Chemical class 0.000 claims abstract description 103
- QQVIHTHCMHWDBS-UHFFFAOYSA-N perisophthalic acid Natural products OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 claims abstract description 47
- 238000010438 heat treatment Methods 0.000 claims abstract description 32
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 21
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 20
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims abstract description 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims description 32
- 239000004593 Epoxy Substances 0.000 claims description 29
- 239000003822 epoxy resin Substances 0.000 claims description 25
- 229920000647 polyepoxide Polymers 0.000 claims description 25
- 125000001424 substituent group Chemical group 0.000 claims description 20
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- ULKLGIFJWFIQFF-UHFFFAOYSA-N 5K8XI641G3 Chemical compound CCC1=NC=C(C)N1 ULKLGIFJWFIQFF-UHFFFAOYSA-N 0.000 claims description 14
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 claims description 13
- LLEASVZEQBICSN-UHFFFAOYSA-N 2-undecyl-1h-imidazole Chemical compound CCCCCCCCCCCC1=NC=CN1 LLEASVZEQBICSN-UHFFFAOYSA-N 0.000 claims description 12
- YTWBFUCJVWKCCK-UHFFFAOYSA-N 2-heptadecyl-1h-imidazole Chemical compound CCCCCCCCCCCCCCCCCC1=NC=CN1 YTWBFUCJVWKCCK-UHFFFAOYSA-N 0.000 claims description 10
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 7
- BJLUCDZIWWSFIB-UHFFFAOYSA-N 5-tert-butylbenzene-1,3-dicarboxylic acid Chemical compound CC(C)(C)C1=CC(C(O)=O)=CC(C(O)=O)=C1 BJLUCDZIWWSFIB-UHFFFAOYSA-N 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- FBHPRUXJQNWTEW-UHFFFAOYSA-N 1-benzyl-2-methylimidazole Chemical compound CC1=NC=CN1CC1=CC=CC=C1 FBHPRUXJQNWTEW-UHFFFAOYSA-N 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 12
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 3
- 239000001257 hydrogen Substances 0.000 abstract description 3
- 238000002076 thermal analysis method Methods 0.000 description 51
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- 239000013078 crystal Substances 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 11
- 210000003000 inclusion body Anatomy 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000010992 reflux Methods 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 125000002252 acyl group Chemical group 0.000 description 5
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 125000002723 alicyclic group Chemical group 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- UYEMGAFJOZZIFP-UHFFFAOYSA-N 3,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC(O)=C1 UYEMGAFJOZZIFP-UHFFFAOYSA-N 0.000 description 2
- XLSZMDLNRCVEIJ-UHFFFAOYSA-N 4-methylimidazole Chemical compound CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920001225 polyester resin Polymers 0.000 description 2
- 239000004645 polyester resin Substances 0.000 description 2
- 239000004848 polyfunctional curative Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- AXJZCJSXNZZMDU-UHFFFAOYSA-N (5-methyl-1h-imidazol-4-yl)methanol Chemical compound CC=1N=CNC=1CO AXJZCJSXNZZMDU-UHFFFAOYSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- HCNHNBLSNVSJTJ-UHFFFAOYSA-N 1,1-Bis(4-hydroxyphenyl)ethane Chemical compound C=1C=C(O)C=CC=1C(C)C1=CC=C(O)C=C1 HCNHNBLSNVSJTJ-UHFFFAOYSA-N 0.000 description 1
- OWEYKIWAZBBXJK-UHFFFAOYSA-N 1,1-Dichloro-2,2-bis(4-hydroxyphenyl)ethylene Chemical compound C1=CC(O)=CC=C1C(=C(Cl)Cl)C1=CC=C(O)C=C1 OWEYKIWAZBBXJK-UHFFFAOYSA-N 0.000 description 1
- LERDAFCBKALCKT-UHFFFAOYSA-N 1,2,3,4,5-pentafluoro-6-(2,3,4-trifluorophenyl)benzene Chemical group FC1=C(F)C(F)=CC=C1C1=C(F)C(F)=C(F)C(F)=C1F LERDAFCBKALCKT-UHFFFAOYSA-N 0.000 description 1
- URFNSYWAGGETFK-UHFFFAOYSA-N 1,2-bis(4-hydroxyphenyl)ethane Natural products C1=CC(O)=CC=C1CCC1=CC=C(O)C=C1 URFNSYWAGGETFK-UHFFFAOYSA-N 0.000 description 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- 125000005926 1,2-dimethylbutyloxy group Chemical group 0.000 description 1
- OUPZKGBUJRBPGC-UHFFFAOYSA-N 1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione Chemical group O=C1N(CC2OC2)C(=O)N(CC2OC2)C(=O)N1CC1CO1 OUPZKGBUJRBPGC-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
- PULOARGYCVHSDH-UHFFFAOYSA-N 2-amino-3,4,5-tris(oxiran-2-ylmethyl)phenol Chemical compound C1OC1CC1=C(CC2OC2)C(N)=C(O)C=C1CC1CO1 PULOARGYCVHSDH-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- UUODQIKUTGWMPT-UHFFFAOYSA-N 2-fluoro-5-(trifluoromethyl)pyridine Chemical compound FC1=CC=C(C(F)(F)F)C=N1 UUODQIKUTGWMPT-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- UIDDPPKZYZTEGS-UHFFFAOYSA-N 3-(2-ethyl-4-methylimidazol-1-yl)propanenitrile Chemical compound CCC1=NC(C)=CN1CCC#N UIDDPPKZYZTEGS-UHFFFAOYSA-N 0.000 description 1
- SZUPZARBRLCVCB-UHFFFAOYSA-N 3-(2-undecylimidazol-1-yl)propanenitrile Chemical compound CCCCCCCCCCCC1=NC=CN1CCC#N SZUPZARBRLCVCB-UHFFFAOYSA-N 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- ODJUOZPKKHIEOZ-UHFFFAOYSA-N 4-[2-(4-hydroxy-3,5-dimethylphenyl)propan-2-yl]-2,6-dimethylphenol Chemical compound CC1=C(O)C(C)=CC(C(C)(C)C=2C=C(C)C(O)=C(C)C=2)=C1 ODJUOZPKKHIEOZ-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- XRBNDLYHPCVYGC-UHFFFAOYSA-N 4-phenylbenzene-1,2,3-triol Chemical group OC1=C(O)C(O)=CC=C1C1=CC=CC=C1 XRBNDLYHPCVYGC-UHFFFAOYSA-N 0.000 description 1
- GKOPXGXLFSTRKU-UHFFFAOYSA-N 5-benzyl-2-methyl-1h-imidazole Chemical compound N1C(C)=NC(CC=2C=CC=CC=2)=C1 GKOPXGXLFSTRKU-UHFFFAOYSA-N 0.000 description 1
- NBDAHKQJXVLAID-UHFFFAOYSA-N 5-nitroisophthalic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC([N+]([O-])=O)=C1 NBDAHKQJXVLAID-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- JVISFJWXUCTPEQ-UHFFFAOYSA-N FC=1NC(=C(N1)CO)CO Chemical compound FC=1NC(=C(N1)CO)CO JVISFJWXUCTPEQ-UHFFFAOYSA-N 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical class OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- PQJSTKGTLFVIJY-UHFFFAOYSA-N benzene-1,4-diol;ethane Chemical compound CC.OC1=CC=C(O)C=C1.OC1=CC=C(O)C=C1.OC1=CC=C(O)C=C1.OC1=CC=C(O)C=C1 PQJSTKGTLFVIJY-UHFFFAOYSA-N 0.000 description 1
- OZBVOUJIBRYLRW-UHFFFAOYSA-N benzene-1,4-diol;methane Chemical compound C.OC1=CC=C(O)C=C1.OC1=CC=C(O)C=C1 OZBVOUJIBRYLRW-UHFFFAOYSA-N 0.000 description 1
- ZUJDBZOGWUBOIX-UHFFFAOYSA-N benzene-1,4-diol;propane Chemical compound CCC.OC1=CC=C(O)C=C1.OC1=CC=C(O)C=C1 ZUJDBZOGWUBOIX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- JRPRCOLKIYRSNH-UHFFFAOYSA-N bis(oxiran-2-ylmethyl) benzene-1,2-dicarboxylate Chemical compound C=1C=CC=C(C(=O)OCC2OC2)C=1C(=O)OCC1CO1 JRPRCOLKIYRSNH-UHFFFAOYSA-N 0.000 description 1
- KIKYOFDZBWIHTF-UHFFFAOYSA-N bis(oxiran-2-ylmethyl) cyclohex-3-ene-1,2-dicarboxylate Chemical compound C1CC=CC(C(=O)OCC2OC2)C1C(=O)OCC1CO1 KIKYOFDZBWIHTF-UHFFFAOYSA-N 0.000 description 1
- XFUOBHWPTSIEOV-UHFFFAOYSA-N bis(oxiran-2-ylmethyl) cyclohexane-1,2-dicarboxylate Chemical compound C1CCCC(C(=O)OCC2OC2)C1C(=O)OCC1CO1 XFUOBHWPTSIEOV-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000005921 isopentoxy group Chemical group 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920003986 novolac Polymers 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AFEQENGXSMURHA-UHFFFAOYSA-N oxiran-2-ylmethanamine Chemical class NCC1CO1 AFEQENGXSMURHA-UHFFFAOYSA-N 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- IGALFTFNPPBUDN-UHFFFAOYSA-N phenyl-[2,3,4,5-tetrakis(oxiran-2-ylmethyl)phenyl]methanediamine Chemical compound C=1C(CC2OC2)=C(CC2OC2)C(CC2OC2)=C(CC2OC2)C=1C(N)(N)C1=CC=CC=C1 IGALFTFNPPBUDN-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/14—Monocyclic dicarboxylic acids
- C07C63/15—Monocyclic dicarboxylic acids all carboxyl groups bound to carbon atoms of the six-membered aromatic ring
- C07C63/24—1,3 - Benzenedicarboxylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/68—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
- C08G59/686—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used containing nitrogen
Definitions
- the present invention relates to a novel clathrate compound, a curing catalyst containing the clathrate compound, a cured resin-forming composition using the curing catalyst, and a cured resin using the cured resin-forming composition.
- the present invention relates to a production method and a cured resin obtained by the production method.
- Epoxy resin has been widely used in various fields because of its excellent mechanical and thermal properties. Imidazole is used as a curing agent to cure strong epoxy resin. The epoxy epoxy resin-imidazole mixed solution is very poor in the stability of one solution because of the early onset of curing! is there.
- an imidazole acid addition salt obtained by adding hydroxybenzoic acid to imidazole see Patent Document 1
- tetrakisphenol compounds for example, 1, 1, 2, 2, —It has been proposed to use an inclusion body of tetrakis (4-hydroxyphenol) ethane (hereinafter referred to as TEP) and imidazole (see Patent Document 2).
- TEP tetrakis (4-hydroxyphenol) ethane
- Patent Document 1 Japanese Patent Publication No. 2638
- Patent Document 2 Japanese Patent Laid-Open No. 11-71449
- An object of the present invention is to suppress a curing reaction at a low temperature to improve the stability of one liquid and to cure the resin effectively by heat treatment ( Inclusion compound).
- the present invention also provides a cured resin-forming composition using a curing catalyst, a method for producing a cured resin using the cured resin-forming composition, and a cured resin obtained by the production method. provide.
- R represents a C1-C6 alkyl group, a C1-C6 alkoxy group, a nitro group, or a hydroxyl group.
- R represents a hydrogen atom, a C1-C10 alkyl group, a phenol group, a benzyl group, or a
- R-R each independently represents a hydrogen atom, a nitro group, or a halogen atom.
- an isophthalic acid compound represented by the formula (I) is a 5 t-polyisophthalic acid or 5-troisophthalic acid compound.
- the present invention also provides (7) a composition for forming an epoxy cured resin, comprising the following component (A) and component (B):
- R represents a C1-C6 alkyl group, a C1-C6 alkoxy group, a nitro group, or a hydroxyl group.
- R is a hydrogen atom, a C1-C10 alkyl group, a phenol group, a benzyl group, or a
- R-R each independently represents a hydrogen atom, a nitro group, or a halogen atom.
- component (B) with respect to 1 mol of the epoxy ring of the epoxy resin as component (A).
- the composition for forming an epoxy cured resin according to the above (7) which contains 0.01 to: L 0 mol of an imidazole compound represented by the formula (II) in the formula, and the formula (9)
- the epoxy curable resin-forming assembly according to (7) or (8) above which is an isophthalic acid compound represented by (I), which is 5-tert-butylisophthalic acid or 5-troisophthalic acid (10)
- the present invention is (11) a method for producing an epoxy cured resin, characterized in that the composition for forming an epoxy cured resin according to the above (7) to (10) is cured by heat treatment, (12) The method for producing an epoxy cured resin according to (11) above, wherein the heating temperature of the heat treatment is 60 to 250 ° C., or (13) (11) or (12) above
- the present invention relates to an epoxy cured resin characterized by being obtained by a production method.
- R represents a C1-C6 alkyl group, a C1-C6 alkoxy group, a nitro group, or a hydroxyl group.
- R represents a hydrogen atom, a C1-C10 alkyl group, a phenyl group, a benzyl group, or a
- R-R each independently represents a hydrogen atom, a nitro group, or a halogen atom.
- R represents a nitro group or a C4 alkyl group.
- a host compound according to (16) above characterized in that it is a C4 alkyl group strength t-butyl group.
- the curing reaction at low temperature is suppressed to improve the stability of one liquid, and the heat treatment is performed to effectively reduce the fat. Can be cured.
- FIG. 1 is a thermal analysis (TGZDTA) chart of the clathrate according to Example 1 of the present invention.
- FIG. 2 is a thermal analysis (DSC) chart according to temperature change of the clathrate according to Example 1 of the present invention.
- FIG. 3 is a thermal analysis (DSC) chart of a clathrate according to Example 1 of the present invention at a fixed temperature (80 ° C.).
- FIG. 4 is a thermal analysis (TGZDTA) chart of the clathrate according to Example 2 of the present invention.
- FIG. 5 is a thermal analysis (DSC) chart by temperature change of the clathrate according to Example 2 of the present invention.
- FIG. 6 is a thermal analysis (DSC) chart at a fixed temperature (80 ° C.) of the clathrate according to Example 2 of the present invention.
- FIG. 7 is a thermal analysis (TGZDTA) chart of the clathrate according to Example 4 of the present invention.
- FIG. 8 is a thermal analysis (DSC) chart by temperature change of the clathrate according to Example 4 of the present invention.
- FIG. 11 is a thermal analysis (TGZDTA) chart of the clathrate according to Example 5 of the present invention.
- FIG. 12 is a thermal analysis (DSC) chart of 2-undecylimidazole and epoxy resin with temperature changes.
- FIG. 13 is a thermal analysis (DSC) chart by temperature change of the clathrate and epoxy resin according to Example 5 of the present invention.
- FIG. 14 is a thermal analysis (TG—DTA) chart of only 2-heptadecylimidazole.
- FIG. 15 is a thermal analysis (TGZDTA) chart of the clathrate according to Example 6 of the present invention.
- FIG. 16 is a thermal analysis (DSC) chart with temperature change of 2-heptadecylimidazole and epoxy resin.
- FIG. 17 is a thermal analysis (DSC) chart according to temperature change of the clathrate and epoxy resin according to Example 6 of the present invention.
- FIG. 18 is a 1 HNMR vector chart of an inclusion body according to Example 1 of the present invention.
- FIG. 19 is an X-ray diffraction pattern of clathrate (5-N02IPA-2E4MZ) and 5--trosophthalic acid (5-NO 2 -IPA) according to Example 1 of the present invention.
- the inclusion complex of the present invention includes an inclusion compound comprising at least an isophthalic acid compound represented by formula (I) and an imidazole compound represented by formula (II).
- the third component which may contain a third component such as a solvent, is not particularly limited as long as it is a product, but is preferably 40 mol% or less, more preferably 35 mol% or less.
- the inclusion compound be composed of an imidazole compound represented by
- the inclusion complex refers to a compound in which two or more molecules are bonded by a bond other than a covalent bond, and more preferably, two or more molecules are other than a covalent bond.
- a crystalline compound bonded by the bonding of The inclusion compound of the present invention containing the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula ( ⁇ ) is an isophthalic compound represented by the formula (I).
- Acid compound and imida represented by formula (II) It can also be said to be a salt formed from a Zolei compound.
- the clathrate compound of the present invention can be used as a resin hardener for polyester resin, epoxy resin, epoxy'polyester resin, etc., and particularly preferably used as an epoxy resin hardener.
- the inclusion complex of the present invention may be in the form of a liquid dissolved in a solvent, but is preferably in the form of a powder (deposited in the solvent). By being in a powder form, it can be used for, for example, a powder coating.
- R represents a C1-C6 alkyl group, a C1-C6 alkoxy group, a nitro group or a hydroxyl group.
- the C1-C6 alkyl group may have a substituent which is preferably a C1-C4 alkyl group.
- Specific examples of the C1-C6 alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a cyclopropyl group, a butyl group, an isobutyl group, an sbutyl group, a tbutyl group, a cyclobutyl group, and a cyclopropylmethyl group.
- the C1-C6 alkoxy group may have a substituent which is preferably a C1-C4 alkoxy group.
- Specific examples of the C1-C6 alkoxy group include methoxy group, ethoxy group, propoxy group, isopropoxy group, butoxy group, isobutoxy group, s butoxy group, t butoxy group, pentoxy group, isopentoxy group, 2-methyl Butoxy, 1-ethylpropoxy, 2-ethylpropoxy, neopentoxy, hexyloxy, 4-methylpentoxy, 3-methylpentoxy, 2-methylpentoxy, 3, 3 dimethylbutoxy Groups, 2,2-dimethylbutoxy group, 1,1-dimethylbutoxy group, 1,2-dimethylbutoxy group, 1,3 dimethylbutoxy group, 2,3 dimethylbutoxy group, and the like.
- the isophthalic acid compound represented by (I) is 5 t-butylisophthalic acid.
- 5-nitroisophthalic acid can be preferably exemplified.
- the C1-C10 alkyl group may have a substituent which is preferably a C1-C6 alkyl group.
- a substituent which is preferably a C1-C6 alkyl group.
- Specific examples of the C1-C10 alkyl group include a heptyl group, an octyl group, a nonyl group, a decyl group and the like in addition to the above-described alkyl group.
- the phenyl group and the benzyl group may have a substituent.
- R to R each independently have a hydrogen atom, a nitro group, a halogen atom, or a substituent.
- a C1-C10 alkyl group a phenyl group, a benzyl group or a C1-C10 acyl group which may have a group.
- the C1-C20 alkyl group is as described above.
- the C1-C20 acyl group which may have a substituent may have a substituent, which may preferably have a substituent which is preferably a C1-C10 acyl group.
- Specific examples that are more preferably an acyl group include a formyl group, a acetyl group, a propiol group, a butyryl group, a valeryl group, and a benzoyl group.
- the alkyl group, the phenyl group, the benzyl group, and the acyl group may have, at least the isophthalic acid compound represented by the formula (I) and the formula (II) It is not particularly limited as long as a solid compound containing an imidazole compound as a constituent element can be obtained, and for example, a hydroxy group can be preferably exemplified.
- imidazole compound represented by the formula (II) 2-ethyl-4-methylimidazole, 2-methylimidazole, 1-benzil 2-methylimidazole, 2-heptadecylimidazole, 2-undecyl imidazole, 2-phenol 4-methyl-5-hydroxymethyl imidazole, 2-phenol imidazole, 2-phenol 4-methyl imidazole, 1 monobenzyl 2-phenol imidazole, 1,2-dimethylimidazole 1-Cyanoethyl-2-methylimidazole, 1-Cyanoethyl-2-ethyl-4-methylimidazole, 1-Cyanoethyl-2-undecylimidazole, 1-Cyanoethyl-2-phenolimidazole, 2-fluoro-4,5 dihydroxymethylimidazole In view of the ease of forming a powdered clathrate compound, 2-ethyl-4-methylimidazole and 2-methylimidazole
- the clathrate compound of the present invention as described above includes the isophthalic acid compound represented by the formula (I) and the formula
- the imidazole compound represented by (II) After the imidazole compound represented by (II) is added to the solvent, it can be obtained by precipitation by carrying out heat treatment or heat reflux with stirring as necessary. Depending on the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula ( ⁇ ) used, the crystalline compound can be obtained by precipitation by the same operation. In consideration of the solubility in the solvent, the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula ( ⁇ ) are dissolved in the solvent, and then the dissolved solutions are mixed. It is preferable to do.
- the solvent water, methanol, ethanol, ethyl acetate, methyl acetate, jetyl ether, dimethyl ether, acetone, methyl ethyl ketone, acetonitrile and the like can be used.
- the ratio of addition of the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula ( ⁇ ) during the production of the inclusion complex of the present invention is represented by the formula (I): It is preferable that the imidazole compound (guest) force represented by the formula ( ⁇ ) is 0.1 to 5.0 moles per mole of the isophthalic acid compound (host) represented. It is better to be ⁇ 3.0 mol! /.
- an isophthalic acid compound represented by the formula (I) and an imidazole compound represented by the formula (II) are dissolved or suspended in a solvent.
- the third component which may contain a third component such as a solvent, is not particularly limited as long as it is a compound that can be obtained after heating, and is preferably 40 mol% or less. It is particularly preferable that it is 20 mol% or less, more preferably 10 mol% or less! / ⁇ is most preferably not containing the third component Prefer U ,.
- the compound of the present invention was heated by dissolving or suspending at least an isophthalic acid compound represented by formula (I) and an imidazole compound represented by formula (II) in a solvent. Afterwards, compounds that can be obtained If it is not particularly limited, after at least isophthalic acid compound represented by formula (I) and imidazole compound represented by formula (II) are dissolved or suspended in a solvent and heated. Preferably, at least the isophthalic acid compound represented by formula (I) and the imidazole compound represented by formula (II) are dissolved in a solvent. Alternatively, it is more preferably a crystalline compound obtained by crystallization after suspending and heating.
- the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula (II) are as described above.
- the solvent the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula (II) are dissolved or suspended in a solvent and heated, and then the compound of the present invention.
- a solvent There is no particular limitation as long as it does not preclude obtaining a suitable solvent in accordance with the isophthalic acid compound represented by formula (I) or the imidazole compound represented by formula (II). Can be selected.
- Specific solvents are as described above.
- the addition ratio of the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula (II) in the production of the compound of the present invention is represented by the formula (I).
- the imidazole compound power represented by the formula (II) is preferably 0.1 to 5.0 moles, and preferably 0.5 to 3.0 moles per mole of isophthalic acid compound. More preferred.
- a compound capable of dissolving or suspending the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula (II) in a solvent Is preferably dissolved in a solvent.
- the total amount of both compounds need not be dissolved in the solvent, but at least a part of the compound may be dissolved in the solvent.
- the heating conditions for producing the compound of the present invention include at least dissolving an isophthalic acid compound represented by the formula (I) and an imidazole compound represented by the formula (II) in a solvent. After heating, it is not particularly limited as long as the compound of the present invention can be obtained, but it can be heated, for example, within a range of 40 to 120 ° C, more preferably within a range of 50 to 90 ° C. Can be heated.
- the heating at the time of producing the compound of the present invention is a solution or suspension containing the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula (II).
- the turbid liquid with stirring force it is more preferable to heat and reflux the solution or suspension, which is preferably carried out with stirring.
- at least the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula (II) are dissolved or suspended in a solvent.
- a solid compound containing at least an isophthalic acid compound represented by the formula (I) and an imidazole compound represented by the formula (II) as constituent elements In particular, for example, an isophthalic acid compound represented by the formula (I) and an imidazole compound represented by the formula (II) are dissolved in a solvent and heated. Later, the solid compound may be precipitated by simply stopping the heating, but it is preferable to leave it overnight at room temperature after heating. After the solid compound is precipitated, the target compound can be obtained by, for example, filtering and drying. Depending on the isophthalic acid compound represented by formula (I) and the type of imidazole compound represented by formula ( ⁇ ), the same operations as those described above for obtaining a solid compound may be performed. Thus, the crystalline compound of the present invention is obtained.
- the compound is the same as the compound of the present invention, at least the isophthalic acid compound represented by the formula (I) and the imidazole compound represented by the formula ( ⁇ ) are dissolved in a solvent and heated. Then, compounds other than the obtained compound are also included in the compound of the present invention.
- the epoxy resin curing catalyst of the present invention is not particularly limited as long as it contains the inclusion complex of the present invention or the compound of the present invention.
- other epoxy resin curing catalysts are available. May further be contained.
- the epoxy cured resin forming composition of the present invention includes an epoxy resin (component (A)) and the inclusion compound of the present invention or the compound of the present invention (component (B)). Ingredients that are not particularly limited as long as they are contained are as described above.
- epoxy resin of component (A) various conventionally known polyepoxy compounds can be used.
- the ratio of the imidazole compound represented by the formula (II) in the component (A) and the component (B) in the epoxy cured resin-forming composition of the present invention is the epoxy which is the component (A). It is preferable to contain 0.01 mole of the imidazole compound represented by the formula (II) in the component (B) with respect to 1 mole of the epoxy ring of the resin. More preferably, it is contained in an amount of 1.0 mol, more preferably 0.3 to 1.0 mol.
- composition for forming an epoxy cured resin of the present invention can be produced by mixing the component (A) and the component (B). Usually, a sufficient mixed state is formed. 60 ⁇ : Heat to LOO ° C and mix. In the production of epoxy cured resin, the stability of one liquid at this temperature is important.
- the method for producing the epoxy curable resin of the present invention is not particularly limited as long as it is a method of curing the epoxy cured resin-forming composition by heat treatment.
- the heating temperature is 60 to 250 ° C, preferably 100 to 200 ° C. It is preferable to cure in a short time at a powerful temperature.
- the host compound for clathrate compounds of the present invention is an isophthalic acid compound represented by the formula (I) (wherein R represents a nitro group or a C4 alkyl group). ) As long as the alkyl group of C4 is preferably t-butyl.
- the host compound for inclusion complex is a compound formed by bonding with one or more other molecules (guest, solvent, etc.) by a bond other than a covalent bond, and A compound that can form an inclusion lattice in the compound, and more preferably, it forms a crystalline compound by bonding to one or more other molecules (guest, solvent, etc.) by a bond other than a covalent bond. And a compound capable of forming an inclusion lattice in the crystalline compound.
- the inclusion lattice means that host compounds are bonded to each other by bonds other than covalent bonds, and other molecules (guests, solvents, etc.), in the gap between two or more molecules of the bonded host compounds.
- other molecules and a host compound are included by a bond other than a covalent bond, or the host compound and another molecule (a guest, a solvent, etc.) are bonded by a bond other than a covalent bond, and other molecules
- the host compound and Z or other molecules are included by a bond other than a covalent bond in a gap between two or three or more molecules of the host compound bonded to the compound.
- the guest compound may be bonded by a bond other than a covalent bond.
- the host compound of the present invention is not affected by the host compound.
- the shape of the inclusion lattice is not particularly limited, and examples thereof include a tunnel shape, a layer shape, and a net shape.
- the host compound of the present invention does not form an inclusion lattice as long as it forms an inclusion lattice with at least a part of the inclusion compound.
- the host compound is included in the inclusion compound. It is preferable to form an inclusion grid with the entire inclusion compound.
- Example 1 To 20 ml of a methanol solution of 5 mmol (l. 05 g) of 5-troisophthalic acid, 20 ml of a methanol solution of 2 ethyl 4-methylimidazole lOmmo l. 10 g) was added with stirring under heating and reflux. Thereafter, crystals were precipitated as soon as the heating was stopped. After standing overnight at room temperature, inclusions were obtained by filtration and vacuum drying (0.5 g, 33%). The obtained clathrate was analyzed by NMR and found to be a 1: 1 clathrate crystal.
- FIG. 18 and 19 show the 1 H NMR spectrum chart and X-ray diffraction pattern of the resulting clathrate (5-N02IPA-2E4MZ), respectively.
- the X-ray diffraction pattern of 5-troisophthalic acid (5-N02-IP A) is shown in FIG.
- Figure 1 shows the thermal analysis (TGZDTA) chart of the clathrate crystals obtained.
- Fig. 2 shows the thermal analysis (DSC) chart of temperature change of the clathrate crystals obtained, and
- Fig. 3 shows the thermal analysis (DSC) chart at a fixed temperature (80 ° C).
- Fig. 10 shows the thermal analysis (TG-DTA) chart of 2-undecylimidazole alone
- Fig. 11 shows the thermal analysis (TG-DTA) chart of the resulting clathrate crystals. Since the melting point of 2-undecylimidazole was not observed in the chart of Fig. 11, the obtained substance is considered to be an inclusion body.
- Fig. 12 shows the thermal analysis (DSC) chart of 2-undecylimidazole and epoxy resin based on the temperature change, and the thermal analysis (DSC) chart based on the temperature change of the resulting clathrate and epoxy resin.
- Figure 13 shows.
- the curing temperature in Fig. 13 is higher than the curing temperature in Fig. 12, indicating that one-component stability is improved by inclusion.
- DSC was measured by mixing with bisphenol A type epoxy resin (YD-128) so as to give imidazole force.
- FIG. 14 shows a thermal analysis (TG-DTA) chart of 2-heptadecylimidazole alone
- FIG. 15 shows a thermal analysis (TG DTA) chart of the resulting clathrate crystals. Since the melting point of 2-undecylimidazole was not observed in the chart of Fig. 15, the obtained substance is considered to be an inclusion body.
- DSC was measured by mixing with bisphenol A type epoxy resin (YD-128) so as to give imidazole force.
- TEP 1, 1, 2, 2, —Tetrakis (4-hydroxyphenenole) ethane (TEP) 75. Og, 2-methylimidazole 31. Og, and 300 ml of ethyl acetate were mixed and heated to reflux for 3 hours. Then, after allowing to cool overnight, the obtained precipitate was filtered and vacuum dried to obtain 95 g of inclusion body (TEP-2MZ).
- a thermal analysis (DSC) chart by temperature change of the obtained clathrate and a thermal analysis (DSC) chart at a fixed temperature (80 ° C.) were measured.
- reaction start temperature is read from the charts shown in Fig. 2 (Example 1), Fig. 5 (Example 2), and Fig. 8 (Example 4).
- Table 1 shows the same graphs of the prepared samples and the comparative example.
- the clathrate according to the example has a high reaction start temperature, and thus the one-component stability is improved.
- the clathrate according to the example has high reactivity of the epoxy ring due to the small temperature difference up to the peak of reaction initiation force.
- reaction start time, peak top, and reaction end time were read from the charts shown in FIG. 3 (Example 1), FIG. 6 (Example 2), and FIG. Table 2 shows the same graphs of the comparison and comparative examples.
- Example 3 (isophthalic acid-ratio 15 cases 4 ⁇ terephthalate 2E4MZ) Actual example 5-nitroisophthalic acid-th * ⁇ 6 (T 2 ⁇ )
- C is a general temperature at the time of mixing the epoxy resin and the clathrate, and it is extremely important to suppress the progress of the reaction at this temperature. From the figure and Table 2, it can be seen that the clathrate according to the example has a very long time until the start of the reaction and the reaction peak, and the one-component stability is extremely high.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Epoxy Resins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020097012444A KR101176809B1 (ko) | 2006-12-21 | 2006-12-21 | 포접 화합물, 경화 촉매, 경화 수지 형성용 조성물 및 경화 수지 |
ES06842980T ES2433681T3 (es) | 2006-12-21 | 2006-12-21 | Compuesto de clatrato, catalizador de endurecimiento, composición para formar una resina endurecida, y resina endurecida |
PCT/JP2006/325472 WO2008075427A1 (ja) | 2006-12-21 | 2006-12-21 | 包接化合物、硬化触媒、硬化樹脂形成用組成物及び硬化樹脂 |
US12/448,248 US20100022744A1 (en) | 2006-12-21 | 2006-12-21 | Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin |
CN2006800567025A CN101563326B (zh) | 2006-12-21 | 2006-12-21 | 包合化合物、固化催化剂、固化树脂形成用组合物及固化树脂 |
EP06842980.2A EP2103600B1 (en) | 2006-12-21 | 2006-12-21 | Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin |
US13/331,772 US8735529B2 (en) | 2006-12-21 | 2011-12-20 | Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2006/325472 WO2008075427A1 (ja) | 2006-12-21 | 2006-12-21 | 包接化合物、硬化触媒、硬化樹脂形成用組成物及び硬化樹脂 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12448248 A-371-Of-International | 2006-12-21 | ||
US13/331,772 Continuation-In-Part US8735529B2 (en) | 2006-12-21 | 2011-12-20 | Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008075427A1 true WO2008075427A1 (ja) | 2008-06-26 |
Family
ID=39536066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/325472 WO2008075427A1 (ja) | 2006-12-21 | 2006-12-21 | 包接化合物、硬化触媒、硬化樹脂形成用組成物及び硬化樹脂 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100022744A1 (ja) |
EP (1) | EP2103600B1 (ja) |
KR (1) | KR101176809B1 (ja) |
CN (1) | CN101563326B (ja) |
ES (1) | ES2433681T3 (ja) |
WO (1) | WO2008075427A1 (ja) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2192139A1 (en) * | 2007-09-21 | 2010-06-02 | Nippon Soda Co., Ltd. | Inclusion complex containing epoxy resin composition for semiconductor encapsulation |
WO2010103809A1 (ja) | 2009-03-11 | 2010-09-16 | 日本曹達株式会社 | エポキシ樹脂組成物、硬化剤及び硬化促進剤 |
WO2010106780A1 (ja) | 2009-03-17 | 2010-09-23 | 日本曹達株式会社 | 包接錯体、硬化剤、硬化促進剤、エポキシ樹脂組成物及び半導体封止用エポキシ樹脂組成物 |
JP2010242074A (ja) * | 2009-03-19 | 2010-10-28 | Nippon Soda Co Ltd | 新規な包接錯体、エポキシ樹脂組成物及び半導体封止用エポキシ樹脂組成物 |
WO2011045941A1 (ja) * | 2009-10-16 | 2011-04-21 | 日本曹達株式会社 | エポキシ硬化樹脂形成用組成物及びその硬化物 |
WO2011089874A1 (ja) * | 2010-01-20 | 2011-07-28 | 日本曹達株式会社 | 包接化合物及びその製造方法 |
WO2011145317A1 (ja) * | 2010-05-21 | 2011-11-24 | 日本曹達株式会社 | 硬化性粉体塗料組成物及びその硬化物 |
JP2012008537A (ja) * | 2010-05-27 | 2012-01-12 | Jsr Corp | 硬化膜形成用感放射線性樹脂組成物、硬化膜形成用感放射線性樹脂組成物の製造方法、硬化膜、硬化膜の形成方法及び表示素子 |
WO2012035755A1 (ja) | 2010-09-15 | 2012-03-22 | 日本曹達株式会社 | 液状の硬化性エポキシ樹脂組成物及びそれを含有する接着剤 |
JP2012063745A (ja) * | 2010-08-16 | 2012-03-29 | Jsr Corp | 着色組成物、着色組成物の製造方法、着色パターン、カラーフィルタ、カラー表示素子及びカラーフィルタの製造方法 |
JP2013136702A (ja) * | 2011-12-28 | 2013-07-11 | Namics Corp | 液状封止材 |
US8735529B2 (en) | 2006-12-21 | 2014-05-27 | Nippon Soda Co., Ltd. | Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin |
WO2016038827A1 (ja) * | 2014-09-08 | 2016-03-17 | 日本曹達株式会社 | 包接化合物の結晶多形、その製造方法及び硬化性樹脂組成物 |
WO2016117298A1 (ja) * | 2015-01-19 | 2016-07-28 | 日本曹達株式会社 | 包接化合物の結晶多形、それを含有する硬化性組成物、及び硬化物 |
KR20170084228A (ko) | 2015-01-19 | 2017-07-19 | 닛뽕소다 가부시키가이샤 | 포접 화합물의 제조 방법 |
WO2020043917A1 (en) | 2018-08-30 | 2020-03-05 | Hexcel Composites Limited | Improvements in or relating to curing agents |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102875470B (zh) * | 2006-12-21 | 2015-09-09 | 日本曹达株式会社 | 包合化合物、固化催化剂、固化树脂形成用组合物及固化树脂 |
CN102375338A (zh) * | 2010-08-16 | 2012-03-14 | Jsr株式会社 | 着色组合物、着色组合物的制造方法、着色图案、滤色器、彩色显示元件以及滤色器的制造方法 |
CN109181483B (zh) * | 2018-09-05 | 2021-02-09 | 安徽泰达新材料股份有限公司 | 一种环氧树脂粉末涂料用消光固化剂及其制备方法与应用 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3746686A (en) * | 1971-07-12 | 1973-07-17 | Shell Oil Co | Process for curing polyepoxides with polycarboxylic acid salts of an imidazole compound and compositions thereof |
JPS56100748A (en) * | 1980-01-18 | 1981-08-12 | Nippon Kayaku Co Ltd | Preparation of n,n'-unsubstituted-5-nitrosophthalic acid diamide |
JPS57135870A (en) * | 1980-12-31 | 1982-08-21 | Mobil Oil Corp | Coating composition |
JPS5876420A (ja) * | 1981-11-02 | 1983-05-09 | Matsushita Electric Works Ltd | エポキシ樹脂成形材料 |
JPS60252620A (ja) * | 1984-05-28 | 1985-12-13 | Mitsubishi Gas Chem Co Inc | 積層板用樹脂組成物 |
JPH08151372A (ja) * | 1994-11-28 | 1996-06-11 | Mita Ind Co Ltd | ビスオキサジアゾール誘導体およびこれを用いた電子写真感光体 |
JPH10511718A (ja) * | 1994-12-28 | 1998-11-10 | ケンブリッジ ディスプレイ テクノロジー リミテッド | 光デバイス用重合体 |
JPH10316639A (ja) * | 1997-05-16 | 1998-12-02 | Mitsui Chem Inc | 5−アミノ−2,4,6−トリヨードイソフタル酸の製造法 |
JPH1171449A (ja) | 1996-12-27 | 1999-03-16 | Nippon Soda Co Ltd | エポキシ樹脂用硬化剤・硬化促進剤及びエポキシ樹脂組成物 |
JP2004503632A (ja) * | 2000-06-10 | 2004-02-05 | エルジー・ケミカル・カンパニー・リミテッド | エポキシ樹脂組成物及びこれを使用した銅箔積層板 |
JP2004300041A (ja) * | 2003-03-31 | 2004-10-28 | Konica Minolta Chemical Co Ltd | 高純度の5−アミノイソフタル酸の製造方法 |
JP2007039449A (ja) * | 2005-07-06 | 2007-02-15 | Nippon Soda Co Ltd | 包接化合物、硬化触媒、硬化樹脂形成用組成物及び硬化樹脂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3847612A (en) * | 1973-02-02 | 1974-11-12 | Minnesota Mining & Mfg | Light-sensitive heat-developable sheet material |
NL170757C (nl) | 1977-04-12 | 1982-12-16 | Akzo Nv | Werkwijze voor het reinigen en tegen roest beschermen van een ijzeren of stalen oppervlak. |
US4420605A (en) * | 1980-12-31 | 1983-12-13 | Mobil Oil Corporation | Coating compositions having dual curing mechanisms |
US6723811B1 (en) * | 1994-12-28 | 2004-04-20 | Cambridge Display Technology Ltd. | Polymers for use in optical device |
KR101132999B1 (ko) * | 2007-09-21 | 2012-04-09 | 닛뽕소다 가부시키가이샤 | 포접 착물을 함유하는 반도체 밀봉용 에폭시 수지 조성물 |
-
2006
- 2006-12-21 ES ES06842980T patent/ES2433681T3/es active Active
- 2006-12-21 US US12/448,248 patent/US20100022744A1/en not_active Abandoned
- 2006-12-21 CN CN2006800567025A patent/CN101563326B/zh not_active Expired - Fee Related
- 2006-12-21 WO PCT/JP2006/325472 patent/WO2008075427A1/ja active Application Filing
- 2006-12-21 KR KR1020097012444A patent/KR101176809B1/ko not_active IP Right Cessation
- 2006-12-21 EP EP06842980.2A patent/EP2103600B1/en not_active Not-in-force
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3746686A (en) * | 1971-07-12 | 1973-07-17 | Shell Oil Co | Process for curing polyepoxides with polycarboxylic acid salts of an imidazole compound and compositions thereof |
JPS56100748A (en) * | 1980-01-18 | 1981-08-12 | Nippon Kayaku Co Ltd | Preparation of n,n'-unsubstituted-5-nitrosophthalic acid diamide |
JPS57135870A (en) * | 1980-12-31 | 1982-08-21 | Mobil Oil Corp | Coating composition |
JPS5876420A (ja) * | 1981-11-02 | 1983-05-09 | Matsushita Electric Works Ltd | エポキシ樹脂成形材料 |
JPS60252620A (ja) * | 1984-05-28 | 1985-12-13 | Mitsubishi Gas Chem Co Inc | 積層板用樹脂組成物 |
JPH08151372A (ja) * | 1994-11-28 | 1996-06-11 | Mita Ind Co Ltd | ビスオキサジアゾール誘導体およびこれを用いた電子写真感光体 |
JPH10511718A (ja) * | 1994-12-28 | 1998-11-10 | ケンブリッジ ディスプレイ テクノロジー リミテッド | 光デバイス用重合体 |
JPH1171449A (ja) | 1996-12-27 | 1999-03-16 | Nippon Soda Co Ltd | エポキシ樹脂用硬化剤・硬化促進剤及びエポキシ樹脂組成物 |
JPH10316639A (ja) * | 1997-05-16 | 1998-12-02 | Mitsui Chem Inc | 5−アミノ−2,4,6−トリヨードイソフタル酸の製造法 |
JP2004503632A (ja) * | 2000-06-10 | 2004-02-05 | エルジー・ケミカル・カンパニー・リミテッド | エポキシ樹脂組成物及びこれを使用した銅箔積層板 |
JP2004300041A (ja) * | 2003-03-31 | 2004-10-28 | Konica Minolta Chemical Co Ltd | 高純度の5−アミノイソフタル酸の製造方法 |
JP2007039449A (ja) * | 2005-07-06 | 2007-02-15 | Nippon Soda Co Ltd | 包接化合物、硬化触媒、硬化樹脂形成用組成物及び硬化樹脂 |
Non-Patent Citations (1)
Title |
---|
See also references of EP2103600A4 |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8735529B2 (en) | 2006-12-21 | 2014-05-27 | Nippon Soda Co., Ltd. | Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin |
US8653160B2 (en) * | 2007-09-21 | 2014-02-18 | Nippon Soda Co., Ltd. | Inclusion complex containing epoxy resin composition for semiconductor encapsulation |
US20100179250A1 (en) * | 2007-09-21 | 2010-07-15 | Nippon Soda Co., Ltd. | Inclusion complex containing epoxy resin composition for semiconductor encapsulation |
EP2192139A4 (en) * | 2007-09-21 | 2012-08-15 | Nippon Soda Co | EPOXY RESIN COMPOSITION CONTAINING INCLUSION COMPLEX FOR ENCAPSULATION OF SEMICONDUCTORS |
EP2192139A1 (en) * | 2007-09-21 | 2010-06-02 | Nippon Soda Co., Ltd. | Inclusion complex containing epoxy resin composition for semiconductor encapsulation |
WO2010103809A1 (ja) | 2009-03-11 | 2010-09-16 | 日本曹達株式会社 | エポキシ樹脂組成物、硬化剤及び硬化促進剤 |
CN103642001A (zh) * | 2009-03-11 | 2014-03-19 | 日本曹达株式会社 | 包合配合物 |
EP2392603A4 (en) * | 2009-03-11 | 2014-03-05 | Nippon Soda Co | EPOXY RESIN COMPOSITION, HARDENERS AND CLEANING ACCENT |
US8623942B2 (en) | 2009-03-11 | 2014-01-07 | Nippon Soda Co., Ltd. | Epoxy resin composition, curing agent, and curing accelerator |
EP2392603A1 (en) * | 2009-03-11 | 2011-12-07 | Nippon Soda Co., Ltd. | Epoxy resin composition, curing agent, and curing accelerator |
KR101331381B1 (ko) | 2009-03-11 | 2013-11-20 | 닛뽕소다 가부시키가이샤 | 에폭시 수지 조성물, 경화제 및 경화 촉진제 |
CN102341430A (zh) * | 2009-03-11 | 2012-02-01 | 日本曹达株式会社 | 环氧树脂组合物、固化剂及固化促进剂 |
JPWO2010103809A1 (ja) * | 2009-03-11 | 2012-09-13 | 日本曹達株式会社 | エポキシ樹脂組成物、硬化剤及び硬化促進剤 |
US20120004377A1 (en) * | 2009-03-17 | 2012-01-05 | Nippon Soda Co., Ltd. | Clathrate, curing agent, cure accelerator, epoxy resin composition, and epoxy resin composition for encapsulation of semiconductor |
EP2410001A4 (en) * | 2009-03-17 | 2014-03-12 | Nippon Soda Co | INCLUSION COMPLEX, CURING AGENT, CURING ACCELERATOR, EPOXY RESIN COMPOSITION, AND EPOXY RESIN COMPOSITION FOR SEMICONDUCTOR ENCAPSULATION |
CN103936676A (zh) * | 2009-03-17 | 2014-07-23 | 日本曹达株式会社 | 包合配合物、固化剂、固化促进剂、环氧树脂组合物及半导体封装用环氧树脂组合物 |
CN102356109A (zh) * | 2009-03-17 | 2012-02-15 | 日本曹达株式会社 | 包合配合物、固化剂、固化促进剂、环氧树脂组合物及半导体封装用环氧树脂组合物 |
US9023956B2 (en) * | 2009-03-17 | 2015-05-05 | Nippon Soda Co., Ltd. | Clathrate, curing agent, cure accelerator, epoxy resin composition, and epoxy resin composition for encapsulation of semiconductor |
WO2010106780A1 (ja) | 2009-03-17 | 2010-09-23 | 日本曹達株式会社 | 包接錯体、硬化剤、硬化促進剤、エポキシ樹脂組成物及び半導体封止用エポキシ樹脂組成物 |
JP2010242074A (ja) * | 2009-03-19 | 2010-10-28 | Nippon Soda Co Ltd | 新規な包接錯体、エポキシ樹脂組成物及び半導体封止用エポキシ樹脂組成物 |
US9068074B2 (en) | 2009-10-16 | 2015-06-30 | Nippon Soda Co., Ltd. | Composition for formation of cured epoxy resin, and cured products thereof |
WO2011045941A1 (ja) * | 2009-10-16 | 2011-04-21 | 日本曹達株式会社 | エポキシ硬化樹脂形成用組成物及びその硬化物 |
JP5474995B2 (ja) * | 2009-10-16 | 2014-04-16 | 日本曹達株式会社 | エポキシ硬化樹脂形成用組成物及びその硬化物 |
WO2011089874A1 (ja) * | 2010-01-20 | 2011-07-28 | 日本曹達株式会社 | 包接化合物及びその製造方法 |
JP5536108B2 (ja) * | 2010-01-20 | 2014-07-02 | 日本曹達株式会社 | 包接化合物及びその製造方法 |
WO2011145317A1 (ja) * | 2010-05-21 | 2011-11-24 | 日本曹達株式会社 | 硬化性粉体塗料組成物及びその硬化物 |
JP2012008537A (ja) * | 2010-05-27 | 2012-01-12 | Jsr Corp | 硬化膜形成用感放射線性樹脂組成物、硬化膜形成用感放射線性樹脂組成物の製造方法、硬化膜、硬化膜の形成方法及び表示素子 |
JP2012063745A (ja) * | 2010-08-16 | 2012-03-29 | Jsr Corp | 着色組成物、着色組成物の製造方法、着色パターン、カラーフィルタ、カラー表示素子及びカラーフィルタの製造方法 |
KR101770180B1 (ko) | 2010-08-16 | 2017-08-22 | 제이에스알 가부시끼가이샤 | 착색 조성물, 착색 조성물의 제조 방법, 착색 패턴, 컬러 필터, 컬러 표시 소자 및 컬러 필터의 제조 방법 |
JPWO2012035755A1 (ja) * | 2010-09-15 | 2014-01-20 | 日本曹達株式会社 | 液状の硬化性エポキシ樹脂組成物及びそれを含有する接着剤 |
WO2012035755A1 (ja) | 2010-09-15 | 2012-03-22 | 日本曹達株式会社 | 液状の硬化性エポキシ樹脂組成物及びそれを含有する接着剤 |
JP2013136702A (ja) * | 2011-12-28 | 2013-07-11 | Namics Corp | 液状封止材 |
WO2016038827A1 (ja) * | 2014-09-08 | 2016-03-17 | 日本曹達株式会社 | 包接化合物の結晶多形、その製造方法及び硬化性樹脂組成物 |
JPWO2016038827A1 (ja) * | 2014-09-08 | 2017-06-08 | 日本曹達株式会社 | 包接化合物の結晶多形、その製造方法及び硬化性樹脂組成物 |
US10266642B2 (en) | 2014-09-08 | 2019-04-23 | Nippon Soda Co., Ltd. | Crystal polymorphism of inclusion compound and method for producing same, and curable resin composition |
WO2016117298A1 (ja) * | 2015-01-19 | 2016-07-28 | 日本曹達株式会社 | 包接化合物の結晶多形、それを含有する硬化性組成物、及び硬化物 |
KR20170084228A (ko) | 2015-01-19 | 2017-07-19 | 닛뽕소다 가부시키가이샤 | 포접 화합물의 제조 방법 |
US10508068B2 (en) | 2015-01-19 | 2019-12-17 | Nippon Soda Co., Ltd. | Production method for inclusion compound |
WO2020043917A1 (en) | 2018-08-30 | 2020-03-05 | Hexcel Composites Limited | Improvements in or relating to curing agents |
Also Published As
Publication number | Publication date |
---|---|
CN101563326B (zh) | 2012-10-31 |
EP2103600B1 (en) | 2013-09-11 |
EP2103600A4 (en) | 2011-05-18 |
KR20090079998A (ko) | 2009-07-22 |
EP2103600A1 (en) | 2009-09-23 |
US20100022744A1 (en) | 2010-01-28 |
CN101563326A (zh) | 2009-10-21 |
KR101176809B1 (ko) | 2012-08-24 |
ES2433681T3 (es) | 2013-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008075427A1 (ja) | 包接化合物、硬化触媒、硬化樹脂形成用組成物及び硬化樹脂 | |
JP5068045B2 (ja) | 包接化合物、硬化触媒、硬化樹脂形成用組成物及び硬化樹脂 | |
US8735529B2 (en) | Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin | |
Fyfe et al. | High-resolution carbon-13 and nitrogen-15 NMR investigations of the mechanism of the curing reactions of cyanate-based polymer resins in solution and the solid state | |
JP2017179120A (ja) | 熱硬化性化合物 | |
Weber et al. | Modular design of hosts involving a rigid succinimide framework and N-bonded lateral groups. Crystalline inclusion properties and crystal structures of inclusion compounds with dioxane, methanol, and DMF | |
EP2980064A1 (en) | Novel inclusion compound | |
JP2011016787A (ja) | 液晶性ベンゾオキサジン系化合物及び液晶性ベンゾオキサジン系重合組成物 | |
JP2012232994A (ja) | 包接化合物、硬化触媒、硬化樹脂形成用組成物及び硬化樹脂 | |
CN102875470B (zh) | 包合化合物、固化催化剂、固化树脂形成用组合物及固化树脂 | |
JP6301504B2 (ja) | 包接化合物の製造方法 | |
JP5601934B2 (ja) | エポキシ樹脂用硬化剤 | |
WO2016117298A1 (ja) | 包接化合物の結晶多形、それを含有する硬化性組成物、及び硬化物 | |
TW200526612A (en) | Method for producing glycidyl 2-hydroxybutyrate | |
KR101891935B1 (ko) | 포접 화합물의 결정 다형, 그 제조 방법 및 경화성 수지 조성물 | |
JP2019137713A (ja) | 熱硬化性組成物 | |
JP7316228B2 (ja) | 化合物および化合物の製造方法 | |
JPS6344567A (ja) | 新規なイミダゾール系ジアミド化合物、該化合物の合成方法および該化合物を有効成分とするポリエポキシ樹脂硬化剤 | |
Amanokura et al. | Curing behavior of epoxy resin initiated by amine-containing inclusion complexes | |
JP6233930B2 (ja) | 新規包接化合物、それを含有するエポキシ樹脂組成物及びその硬化物 | |
JPS61183316A (ja) | 一液性エポキシ樹脂用潜在性硬化剤 | |
JP2018150485A (ja) | 包接化合物 | |
WO2020017331A1 (ja) | 新規なポリアシルオキシメチル-4,4'-アシルオキシビフェニル化合物 | |
JP2014122181A (ja) | 芳香族ポリアミン包接化合物 | |
JPS63264539A (ja) | 2,2’,6,6’−テトラヒドロキシ−1,1’−ビナフチル類 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680056702.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06842980 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12448248 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097012444 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006842980 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |